Skip to content

Non-invasive individualized precision neuromodulation therapy for articulation disorders and exploration of the underlying neural plasticity mechanisms

Non-invasive individualized precision neuromodulation therapy for articulation disorders and exploration of the underlying neural plasticity mechanisms

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119611
Enrollment
Unknown
Registered
2026-02-28
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysarthria after stroke

Interventions

Infrastructural group:Neuromodulation therapy
Supratentorial group:Neuromodulation therapy

Sponsors

Beijing Bo'ai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients with DYS after stroke, onset within one week to one year; 2.Age 18-80; 3.Mother tongue is Chinese, speak Putonghua; 4.Patients with clinically confirmed DYS were scored from 0 to 26 on the modified Frenchay rating scale, and were excluded using the modified Boston aphasia diagnostic scale; 5.Patients can keep your wheelchair; 6.right-handed; 7.There are no contraindications to MRI; 8.Normal or corrected vision with no special growth or educational environment; 9.All subjects had not received speech rehabilitation training; 10.No history of mental illness, no history of substance abuse;

Exclusion criteria

Exclusion criteria: 1.There is a serious consciousness disorder, cognitive impairment; 2.There are serious complications (such as heart failure, kidney failure, cancer, etc.); 3.Combined Visual and hearing impairment; 4.Stuttering in the past; 5.Unable to cooperate with relevant assessment and inspection; 6.Refuse to take part in this experiment;

Design outcomes

Primary

MeasureTime frame
Frenchay;

Countries

China

Contacts

Public ContactXiaoxia Du

Beijing Bo'ai Hospital

364906784@qq.com+86 10 87569850

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026